Regenxbio Newsroom

RBC Capital Reiterates Outperform on Regenxbio, Maintains $35 Price Target

BenzingaDec 11 23:55

Regenxbio Analyst Ratings

BenzingaDec 11 23:54

RBC Capital Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $35

Futu NewsDec 11 20:33

H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $36

Futu NewsNov 21 19:31

Buy Rating on RegenXBio Driven by Positive RGX-202 Trial Results and Strong Approval Prospects

TipRanksNov 21 19:19

Barclays Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $50

Futu NewsNov 21 18:36

REGENXBIO Is Maintained at Buy by Chardan Capital

Dow JonesNov 20 19:11

REGENXBIO Price Target Maintained With a $52.00/Share by Chardan Capital

Dow JonesNov 20 19:11

Regenxbio Analyst Ratings

BenzingaNov 20 19:02

BofA Securities Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $25

Futu NewsNov 19 22:31

Stifel Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $40

Futu NewsNov 19 22:31

Stifel Nicolaus Sticks to Its Buy Rating for RegenXBio (RGNX)

TipRanksNov 19 21:38

A Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $18 to $50

Futu NewsNov 19 21:01

Promising Developments in RegenXBio's RGX-202 Program Drive Buy Rating

TipRanksNov 19 01:47

Morgan Stanley Initiates Regenxbio(RGNX.US) With Buy Rating, Announces Target Price $22

Futu NewsNov 15 18:37

RBC Capital Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $35

Futu NewsNov 12 20:36

Barclays Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $50

Futu NewsNov 8 18:37

Regenxbio Analyst Ratings

BenzingaNov 8 04:34

Stifel Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $40

Futu NewsNov 7 23:34

RBC Capital Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $35

Futu NewsNov 7 20:32